 |
Witnesses: Janet Heinrich, DrPH, RN, Dir. of Health Care-Public Health Issues, Gen. Accounting Office (GAO); Steven Galson, M.D. MPH, Deputy Dir., Center for Drug Evaluation & Research, Food & Drug Admin. (FDA); Sarah L. Sellers, PHARM.D, Exec. Dir., The Center for Pharmaceutical Safety; Daniel A. Herbert, RPh, Pres. Elect, Amer. Pharmacists Assoc.; Kevin Kinkade, Exec. Dir., Missouri Board of Pharmacy; William Kennedy, owner, Nephron Pharmaceuticals Corp.; & Senators Christopher S. Bond from MO, John Ensign from NV, & Pat Roberts from KS. Additional Material: Statements, articles, publications, letters, etc., such as: Amer. Soc. of Health-System Pharmacists; & Amer. Pharmacists Assoc.
|
|
|
